Cargando…

Epidemiology of carbapenem-resistant and carbapenemase-producing Enterobacterales in the Netherlands 2017–2019

BACKGROUND: The Netherlands is currently considered a low endemic country for carbapenem-resistant Enterobacterales (CRE) and carbapenemase-producing Enterobacterales (CPE), experiencing only sporadic hospital outbreaks. This study aims to describe susceptibility to carbapenems and the epidemiology...

Descripción completa

Detalles Bibliográficos
Autores principales: Wielders, Cornelia C. H., Schouls, Leo M., Woudt, Sjoukje H. S., Notermans, Daan W., Hendrickx, Antoni P. A., Bakker, Jacinta, Kuijper, Ed J., Schoffelen, Annelot F., de Greeff, Sabine C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8994189/
https://www.ncbi.nlm.nih.gov/pubmed/35397546
http://dx.doi.org/10.1186/s13756-022-01097-9
_version_ 1784684058693861376
author Wielders, Cornelia C. H.
Schouls, Leo M.
Woudt, Sjoukje H. S.
Notermans, Daan W.
Hendrickx, Antoni P. A.
Bakker, Jacinta
Kuijper, Ed J.
Schoffelen, Annelot F.
de Greeff, Sabine C.
author_facet Wielders, Cornelia C. H.
Schouls, Leo M.
Woudt, Sjoukje H. S.
Notermans, Daan W.
Hendrickx, Antoni P. A.
Bakker, Jacinta
Kuijper, Ed J.
Schoffelen, Annelot F.
de Greeff, Sabine C.
author_sort Wielders, Cornelia C. H.
collection PubMed
description BACKGROUND: The Netherlands is currently considered a low endemic country for carbapenem-resistant Enterobacterales (CRE) and carbapenemase-producing Enterobacterales (CPE), experiencing only sporadic hospital outbreaks. This study aims to describe susceptibility to carbapenems and the epidemiology of carbapenemase production in Enterobacterales in the Netherlands in 2017–2019. METHODS: Three complementary nationwide surveillance systems are in place to monitor carbapenem susceptibility in the Netherlands. Routine antimicrobial susceptibility test results from medical microbiology laboratories were used to study phenotypic susceptibility of Escherichia coli and Klebsiella pneumoniae. Pathogen surveillance (of all Enterobacterales species) and mandatory notifications were used to describe the characteristics of CPE positive isolates and affected persons. RESULTS: The prevalence of isolates with gradient strip test-confirmed elevated meropenem (> 0.25 mg/L) or imipenem (> 1 mg/L) minimum inhibitory concentration (MIC) in the Netherlands was very low in 2017–2019, with percentages of 0.06% in E. coli and 0.49% in K. pneumoniae, and carbapenem resistances of 0.02% and 0.18%, respectively. A total of 895 unique species/carbapenemase-encoding allele combinations of CPE from 764 persons were submitted between 2017 and 2019, with the annual number of submissions increasing slightly each year. Epidemiological data was available for 660 persons. Screening because of presumed colonisation risk was the reason for sampling in 70.0% (462/660) of persons. Hospitalization abroad was the most common risk factor, being identified in 45.9% of persons. CONCLUSIONS: Carbapenem resistance of E. coli and K. pneumoniae remains low in the Netherlands. The annual number of CPE isolates slightly increased during the period 2017–2019. Recent hospitalization abroad is the main risk factor for acquisition of CPE. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13756-022-01097-9.
format Online
Article
Text
id pubmed-8994189
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-89941892022-04-10 Epidemiology of carbapenem-resistant and carbapenemase-producing Enterobacterales in the Netherlands 2017–2019 Wielders, Cornelia C. H. Schouls, Leo M. Woudt, Sjoukje H. S. Notermans, Daan W. Hendrickx, Antoni P. A. Bakker, Jacinta Kuijper, Ed J. Schoffelen, Annelot F. de Greeff, Sabine C. Antimicrob Resist Infect Control Research BACKGROUND: The Netherlands is currently considered a low endemic country for carbapenem-resistant Enterobacterales (CRE) and carbapenemase-producing Enterobacterales (CPE), experiencing only sporadic hospital outbreaks. This study aims to describe susceptibility to carbapenems and the epidemiology of carbapenemase production in Enterobacterales in the Netherlands in 2017–2019. METHODS: Three complementary nationwide surveillance systems are in place to monitor carbapenem susceptibility in the Netherlands. Routine antimicrobial susceptibility test results from medical microbiology laboratories were used to study phenotypic susceptibility of Escherichia coli and Klebsiella pneumoniae. Pathogen surveillance (of all Enterobacterales species) and mandatory notifications were used to describe the characteristics of CPE positive isolates and affected persons. RESULTS: The prevalence of isolates with gradient strip test-confirmed elevated meropenem (> 0.25 mg/L) or imipenem (> 1 mg/L) minimum inhibitory concentration (MIC) in the Netherlands was very low in 2017–2019, with percentages of 0.06% in E. coli and 0.49% in K. pneumoniae, and carbapenem resistances of 0.02% and 0.18%, respectively. A total of 895 unique species/carbapenemase-encoding allele combinations of CPE from 764 persons were submitted between 2017 and 2019, with the annual number of submissions increasing slightly each year. Epidemiological data was available for 660 persons. Screening because of presumed colonisation risk was the reason for sampling in 70.0% (462/660) of persons. Hospitalization abroad was the most common risk factor, being identified in 45.9% of persons. CONCLUSIONS: Carbapenem resistance of E. coli and K. pneumoniae remains low in the Netherlands. The annual number of CPE isolates slightly increased during the period 2017–2019. Recent hospitalization abroad is the main risk factor for acquisition of CPE. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13756-022-01097-9. BioMed Central 2022-04-09 /pmc/articles/PMC8994189/ /pubmed/35397546 http://dx.doi.org/10.1186/s13756-022-01097-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Wielders, Cornelia C. H.
Schouls, Leo M.
Woudt, Sjoukje H. S.
Notermans, Daan W.
Hendrickx, Antoni P. A.
Bakker, Jacinta
Kuijper, Ed J.
Schoffelen, Annelot F.
de Greeff, Sabine C.
Epidemiology of carbapenem-resistant and carbapenemase-producing Enterobacterales in the Netherlands 2017–2019
title Epidemiology of carbapenem-resistant and carbapenemase-producing Enterobacterales in the Netherlands 2017–2019
title_full Epidemiology of carbapenem-resistant and carbapenemase-producing Enterobacterales in the Netherlands 2017–2019
title_fullStr Epidemiology of carbapenem-resistant and carbapenemase-producing Enterobacterales in the Netherlands 2017–2019
title_full_unstemmed Epidemiology of carbapenem-resistant and carbapenemase-producing Enterobacterales in the Netherlands 2017–2019
title_short Epidemiology of carbapenem-resistant and carbapenemase-producing Enterobacterales in the Netherlands 2017–2019
title_sort epidemiology of carbapenem-resistant and carbapenemase-producing enterobacterales in the netherlands 2017–2019
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8994189/
https://www.ncbi.nlm.nih.gov/pubmed/35397546
http://dx.doi.org/10.1186/s13756-022-01097-9
work_keys_str_mv AT wielderscorneliach epidemiologyofcarbapenemresistantandcarbapenemaseproducingenterobacteralesinthenetherlands20172019
AT schoulsleom epidemiologyofcarbapenemresistantandcarbapenemaseproducingenterobacteralesinthenetherlands20172019
AT woudtsjoukjehs epidemiologyofcarbapenemresistantandcarbapenemaseproducingenterobacteralesinthenetherlands20172019
AT notermansdaanw epidemiologyofcarbapenemresistantandcarbapenemaseproducingenterobacteralesinthenetherlands20172019
AT hendrickxantonipa epidemiologyofcarbapenemresistantandcarbapenemaseproducingenterobacteralesinthenetherlands20172019
AT bakkerjacinta epidemiologyofcarbapenemresistantandcarbapenemaseproducingenterobacteralesinthenetherlands20172019
AT kuijperedj epidemiologyofcarbapenemresistantandcarbapenemaseproducingenterobacteralesinthenetherlands20172019
AT schoffelenannelotf epidemiologyofcarbapenemresistantandcarbapenemaseproducingenterobacteralesinthenetherlands20172019
AT degreeffsabinec epidemiologyofcarbapenemresistantandcarbapenemaseproducingenterobacteralesinthenetherlands20172019
AT epidemiologyofcarbapenemresistantandcarbapenemaseproducingenterobacteralesinthenetherlands20172019
AT epidemiologyofcarbapenemresistantandcarbapenemaseproducingenterobacteralesinthenetherlands20172019